Rashid Mahmood
Surge Laboratories, Pakistan
Scientific Tracks Abstracts: Int J Drug Dev & Res
In the pharmaceutical industry every product and every process associated with risks. To maintain product quality throughout the product life cycle, too much time and resources are allocated. Risk is described in - recent guidance as a combination of the probability of occurrence of harm and the severity of that harm. The Quality Risk Management (QRM) approach initiated by regulatory agencies with recognized management tools along with support of statistic al tools in combination allows for a risk-based approach to quality management, thus ensuring that resources are deployed in a timely and expeditious manner to areas that need them most. QRM improves risk awareness and accelerates detection of potential issues by analyzing and comparing existing data from a quality perspective to manage product quality, manufacturing processes, validation and compliance within a risk based Quality Management System. In addition quality risk management improves decision making if a quality problem arises. It should include systemic processes designated to coordinate, facilitate and improve science-based decision-making with respect to risk. Quality Risk Management can be applied not only in the manufacturing environment, but also in connection with pharmaceutical development and preparation of the quality part of marketing authorization dossiers. The guideline applies also to the regulatory authorities in the fields of pharmaceutical assessment of the quality part of the marketing authorization dossier, GMP inspections and the handling of suspected quality defects. ICH Q9 - Quality Risk Management provides an excellent high-level framework for the use of risk management in pharmaceutical product development and manufacturing quality decision making applications. It is a landmark document in acknowledging risk management as a standard and acceptable quality system practice to facilitate good decision-making wit h regard to risk identification, resource prioritization and risk mitigation / elimination, as appropriate.
Rashid Mahmood has a Master’s Degree in Analytical Chemistry and MS in Total Quality Management. He has 14 years of experience in pharmaceutical quality operations and has participated in many international conferences as a Keynote Speaker. He has presented various talks in USA, Canada and China on cleaning validation, cgmp guidelines and quality risk management. Currently, he is working as a Senior Executive Manager, Quality Operations for Surge Labs, Pakistan. He is engaged in the manufacturing of microencapsulated APIs, liquid and dry powder parenterals. Email:rashid.mahmood@surgelaboratories.com
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
